Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
molecular-diagnostics
Press Release
Oct 23, 2024
SpeeDx Appoints Jeremy Stackawitz as Chief Executive Officer to Drive Global Expansion of Its Molecular Diagnostics Solutions
Read More
Press Release
Mar 23, 2023
BioGX Candida auris PCR Assay Adoption Accelerates
Read More
Press Release
Feb 28, 2023
BioGX Ships First Batch of pixl™ Real-Time PCR Platform to US Laboratories
Read More
Press Release
Dec 8, 2022
BioGX Launches 'pixl™' Portable qPCR Platform Ex-US With Expanded Test Menu for Infectious Diseases
Read More
Press Release
Oct 18, 2022
Patients Choice Laboratories Acquires Infinity Laboratories, LLC to Better Provide Complete Suite of Services to Providers in the Southern U.S.
Read More
Press Release
Oct 18, 2021
Inherent Biosciences Launches Path Fertility - Epigenetic Sperm Quality Test (SpermQT)
SpermQT analyzes the molecular function of sperm and is 6x more predictive of fertility potential than standard semen analysis
Read More
Press Release
Jul 13, 2021
Animal Diagnostics Market Revenue to Cross USD 7.8 Bn by 2027: Global Market Insights Inc.
The Brazil animal diagnostics market is expected to hit USD 287 million by 2027, owing to the rising number of companion animal ownership and increasing prevalence of infectious & parasitic diseases across the country.
Read More
Press Release
Mar 16, 2021
P23 Labs First Saliva-Based Test Authorized for Use in Canada
P23 Labs saliva-based 'P23 at-home COVID-19 Test Collection Kit' is first of its kind approved by Health Canada
Read More
Press Release
Sep 28, 2020
PCR-Dx Diagnostic Launches New Website Highlighting Polymerase Chain Reaction Services to Georgia and Beyond
Read More
Press Release
Jun 16, 2020
Baylor Genetics Launches Testing for COVID-19
Read More
Press Release
Apr 14, 2020
Patients Choice Laboratories Launches Coronavirus Disease 2019 (COVID-19) Testing
Read More
Press Release
Mar 3, 2020
New IDTechEx Research Reports Identify Technologies for the Future of Healthcare
Read More
Press Release
Feb 12, 2020
Molecular Diagnostics Sits at Heart of the Fight Against the Coronavirus, According to New IDTechEx Report
Read More
Press Release
Jun 25, 2018
bioMONTR Labs Announces Laboratory Service Agreement With ViiV Healthcare
Read More
Press Release
Jan 31, 2018
CytoTest Boosts Global Sales Team
CytoTest announces a significant expansion of its sales team.
Read More
Press Release
Jan 10, 2018
MutantDx Liquid Biopsy Detects Cancer Long Before Symptoms Develop
Cancer DNA mutations can now be detected in the blood in femtogram concentrations (one femtogram = one thousand trillionth of a gram)
Read More
Press Release
Jun 23, 2017
New 10-Minute Saliva and Blood Test to Detect Cancer Early
Researchers from Ram Group's Israeli team developed a breakthrough in molecular diagnostic sensors detecting cancer early before metastasis
Read More
Press Release
May 3, 2017
bioMONTR Labs' Laboratory Director Receives Achievement Award
Read More
Press Release
Jan 25, 2017
bioMONTR Labs Announces Laboratory Service Agreements with ViiV Healthcare
Read More
Press Release
Oct 13, 2016
bioMONTR Labs to Provide Testing Services for CytoDyn PRO 140 Clinical Trials
Read More
Press Release
Feb 2, 2015
Molecular Diagnostics Company Oncgnostics Gmbh Closes Series a Financing round for Ce Mark and Market Entry of Its Cervical Cancer Diagnostics Test Gyntect®
oncgnostics develops, based on proprietary epigenetic biomarkers molecular tests for reliable cancer diagnostics. This test allows reliable diagnostics of cervical cancer and its pre-stages. Now oncgnostics has raised a seven-digit Euro amount in a Series A financing round.
Read More
Press Release
Sep 6, 2012
Trovagene Highlighted in Molecular Diagnostics Report
Stock analyst selects Trovagene and two others as companies to consider in view of expected growth and profits in molecular diagnostics
Read More
Press Release
Jun 19, 2011
Intervention Insights Releases Conference Report, "Personalized Medicine: Promises and Perils for Community Oncology and Payers."
Intervention Insights, Inc., a company that offers a personalized medicine service for oncologists, released a report summarizing the inaugural conference, Personalized Medicine: Promises and Perils for Community Oncology and Payers.
Read More
Press Release
Mar 8, 2011
Diagnostic and Prognostic Biomarker Database Launched
A database of 29,000 unique biomarkers (for more than 1800 human diseases), which are manually extracted from US patent/WO (PCT) publications and PubMed abstracts.
Read More
First
Prev
1
Next
Last